Interactions between TGFbeta and retinoid signaling in cardiac development
Interactions between TGFbeta and retinoid signaling in cardiac development
批准号:
7689941
负责人:
Loretta L. Jophlin
金额:
$3.45万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-01 至 2011-08-31
关键词:
AffectAnimalsApoptosisBreedingCardiacCellsCessation of lifeChildhoodCongenital Heart DefectsDataDefectDevelopmentEventFeedbackFetal DeathFutureGene DosageHeartHeart failureHumanKnock-outKnockout MiceLeadLive BirthMesenchymalModelingMolecularMorbidity - disease rateMusNatureNeonatalOperative Surgical ProceduresOutcomePathway interactionsPatientsPhenocopyPhenotypePreventionRetinoid X Receptor alphaRetinoidsRoleSecondary toSignal TransductionSignaling MoleculeTGFB1 geneTGFB2 geneTherapeuticTissuesTransforming Growth Factor Beta 2Transforming Growth Factor betaWorkattenuationcardiogenesiscell growthcongenital heart disordercytokinemortalitypreventpublic health relevanceresearch studytherapeutic development
中文摘要
描述(由申请人提供):先天性心脏缺陷影响1/200的活产儿,其中许多缺陷的手术结果很差。最近的研究表明,新生儿或儿科时期的外科治疗在成年后会导致显著的发病率和死亡率[1]。为了在未来有更好的患者结果,显然需要替代疗法来治疗和预防先天性心脏病。为了创造有效的治疗方法来预防或治疗这些缺陷,必须揭示控制正常和异常心脏发育的分子事件。维甲酸X受体α基因敲除小鼠(RXRA-/-)表现出心脏缺陷,这与人类先天性心脏病的病例相似。在这只小鼠中,由于心垫组织的可塑性低下,没有发生适当的室壁和流出道(OFT)分隔,胎儿死亡发生在妊娠晚期由于心力衰竭[2]。转化生长因子β2(32),一种影响细胞生长、分化和凋亡的细胞因子,在RXRA-/-与野生型(WT)动物的心脏中上调[3]。这种TGF02信号的增加与RXRA-/-心脏中的凋亡增加有关,当这些敲除基因被培育到TGFB2背景上时,显示出OFT间隔缺陷的减弱[3]。这些数据表明,维甲酸和TGFb通路相交,调节心脏发育,初步研究支持维甲酸信号和TGFB2(即Smad2)下游信号分子之间直接相互作用的可能性[66]。这项拟议的研究将确定这些相互作用的性质及其在心脏发育过程中的相关性。我们假设,TGFb和维甲酸信号之间的直接相互作用调节心脏发育的关键方面,特别是OFT重塑。将对TGFb和视黄醇途径的参与者进行空间和时间表征,以确定在RXRA-/-中起作用的任何相关的规范反馈机制。此外,Smad2和Smads杂合性对RXRA-/-的影响将在形态和分子水平上进行研究。公共卫生相关性:这些实验将更好地理解控制心脏正常和异常发育的分子事件。我们希望,这些研究产生的发现将最终导致更好地治疗先天性心脏病的治疗方法的发展。
英文摘要
DESCRIPTION (provided by applicant): Congenital heart defects affect 1/200 live births and many of these defects have poor surgical outcomes. Recently it has been shown that surgical cures during the neonatal or pediatric period can result in significant morbidity and mortality later in adulthood [1]. In order to have better patient outcomes in the future it is evident that alternate therapies are needed for the treatment and prevention of congenital heart diseases. To create useful therapeutics directed at preventing or treating these defects, the molecular events controlling normal and aberrant heart development must be uncovered. The retinoid X receptor alpha knockout mouse (RXRa-/-) shows cardiac defects which phenocopy human cases of congenital heart disease. In this mouse, proper chamber and outflow tract (OFT) septation does not occur due to hypoplasticity of cardiac cushion tissue and fetal death occurs in late-midgestation due to cardiac failure [2]. Transforming growth factor beta 2 (TGF(32), a cytokine affecting cellular growth, differentiation, and apoptosis is upregulated in the hearts of RXRa-/- versus wild type (WT) animals [3]. This increase in TGF02 signaling is related to increased apoptosis in the RXRa-/- heart and these knockouts, when bred onto a TGFB2 background show an attenuation of OFT septation defects [3]. These data suggest that the retinoid and TGFB pathways intersect to regulate cardiac development and preliminary studies support the potential for direct interaction between retinoid signaling and signaling molecules downstream of TGFB2 (i.e. Smad2) [66]. The proposed study will establish the nature of these interactions and their relevance during heart development. We hypothesize that direct interactions between TGFB and retinoid signaling regulate critical aspects of cardiac development particularly OFT remodeling. Spatial and temporal characterization of TGFB and retinoid pathway players will be performed to determine any relevant canonical feedback mechanisms at work in the RXRa-/-. Additionally, the effects of heterozygosity for Smad2 and SmadS on the RXRa-/- will be investigated on the morphological and molecular levels. Public Health Relevance: These experiments will yield a better understanding of the molecular events controlling normal and aberrant cardiac development. It is our hope that discoveries generated from these studies will lead to the eventual development of therapeutics to better treat congenital heart disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interaction of the Microtubule Cytoskeleton and Perilipin-2 Regulates Hepatic Lipid Droplets - a Potential Therapeutic Target for Fatty Liver Disease
-
批准号:10596083
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2021
-
负责人:Loretta L. Jophlin
-
依托单位:
Interaction of the Microtubule Cytoskeleton and Perilipin-2 Regulates Hepatic Lipid Droplets - a Potential Therapeutic Target for Fatty Liver Disease
-
批准号:10375465
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2021
-
负责人:Loretta L. Jophlin
-
依托单位:
The retinoid burst in hepatic stellate cell mediated liver fibrosis
-
批准号:9033667
-
项目类别:
-
资助金额:$3.44万
-
财政年份:2016
-
负责人:Loretta L. Jophlin
-
依托单位:
The retinoid burst in hepatic stellate cell mediated liver fibrosis
-
批准号:8909992
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2016
-
负责人:Loretta L. Jophlin
-
依托单位:
Interactions between TGFbeta and retinoid signaling in cardiac development
-
批准号:7541574
-
项目类别:
-
资助金额:$3.34万
-
财政年份:2008
-
负责人:Loretta L. Jophlin
-
依托单位:
海外基金